FI974170A - B-adrenergisiä agonisteja - Google Patents
B-adrenergisiä agonisteja Download PDFInfo
- Publication number
- FI974170A FI974170A FI974170A FI974170A FI974170A FI 974170 A FI974170 A FI 974170A FI 974170 A FI974170 A FI 974170A FI 974170 A FI974170 A FI 974170A FI 974170 A FI974170 A FI 974170A
- Authority
- FI
- Finland
- Prior art keywords
- adrenergic agonists
- adrenergic
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002220538A CA2220538A1 (en) | 1995-05-10 | 1995-05-10 | .beta.-adrenergic agonists |
| PCT/IB1995/000342 WO1996035670A1 (en) | 1995-05-10 | 1995-05-10 | β-ADRENERGIC AGONISTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI974170A true FI974170A (fi) | 1997-11-07 |
| FI974170A0 FI974170A0 (fi) | 1997-11-07 |
Family
ID=25679804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI974170A FI974170A0 (fi) | 1995-05-10 | 1997-11-07 | B-adrenergisiä agonisteja |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0828712A1 (de) |
| JP (1) | JPH11504648A (de) |
| CN (1) | CN1144801A (de) |
| CA (1) | CA2220538A1 (de) |
| FI (1) | FI974170A0 (de) |
| WO (1) | WO1996035670A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981562A (en) * | 1996-01-30 | 1999-11-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| CN1237160A (zh) * | 1996-11-14 | 1999-12-01 | 辉瑞大药厂 | 取代的吡啶的制备方法 |
| US6001856A (en) * | 1997-06-13 | 1999-12-14 | Pfizer Inc. | β-adrenergic agonists to reduce a wasting condition |
| ES2149742T1 (es) * | 1997-07-03 | 2000-11-16 | Asahi Chemical Ind | Nuevos compuestos triciclicos que tienen anillos saturados y composiciones medicinales que contienen los mismos. |
| EP0920864A1 (de) * | 1997-12-03 | 1999-06-09 | Pfizer Products Inc. | Kombinationstherapie durch einen spezifischen beta-3 Agonisten und einen Appetithemmer |
| US6090942A (en) * | 1998-10-15 | 2000-07-18 | Pfizer Inc. | Process and intermediates for a β3 -adrenergic receptor agonist |
| CN1430603A (zh) * | 2000-04-28 | 2003-07-16 | 旭化成株式会社 | 新型双环化合物 |
| DE60239170D1 (de) | 2001-10-25 | 2011-03-24 | Asahi Kasei Pharma Corp | Bicyclische Verbindungen |
| RU2006119331A (ru) * | 2003-11-03 | 2007-12-27 | БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ АГОНИСТ β3-АДРЕНОРЕЦЕПТОРА, α-АНТАГОНИСТ И/ИЛИ ИНГИБИТОР 5α-РЕДУКТАЗЫ |
| US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
| US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
| KR20160129109A (ko) | 2008-05-23 | 2016-11-08 | 아미라 파마슈티칼스 인코포레이티드 | 5-리폭시게나아제 활성화 단백질 억제제 |
| EP2351742A4 (de) | 2008-10-09 | 2012-03-28 | Asahi Kasei Pharma Corp | Indazolderivate |
| JPWO2010041569A1 (ja) | 2008-10-09 | 2012-03-08 | 旭化成ファーマ株式会社 | インダゾール化合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4358455A (en) * | 1980-12-23 | 1982-11-09 | Merck & Co., Inc. | Aralkylamindethanol heterocyclic compounds |
| EP0105053B1 (de) * | 1982-10-01 | 1988-01-20 | Merck & Co. Inc. | Heterocyclische Aralkylaminoethanol-Verbindungen |
| GB8703007D0 (en) * | 1987-02-10 | 1987-03-18 | Glaxo Group Ltd | Chemical compounds |
| US5019578A (en) * | 1987-11-27 | 1991-05-28 | Merck & Co., Inc. | β-adrenergic agonists |
| NZ226991A (en) * | 1987-11-27 | 1992-03-26 | Merck & Co Inc | Alpha-heterocyclically-substituted ethanolamines and use as animal growth promotors |
| US5726192A (en) * | 1992-12-29 | 1998-03-10 | Smithkline Beecham Corporation | Platelet aggregation inhibiting compounds |
| CA2164009A1 (en) * | 1993-06-14 | 1994-12-22 | Robert L. Dow | Secondary amines as antidiabetic and antiobesity agents |
-
1995
- 1995-05-10 EP EP95915993A patent/EP0828712A1/de not_active Withdrawn
- 1995-05-10 CA CA002220538A patent/CA2220538A1/en not_active Abandoned
- 1995-05-10 WO PCT/IB1995/000342 patent/WO1996035670A1/en not_active Application Discontinuation
- 1995-05-10 JP JP8533902A patent/JPH11504648A/ja active Pending
-
1996
- 1996-05-07 CN CN96105900A patent/CN1144801A/zh active Pending
-
1997
- 1997-11-07 FI FI974170A patent/FI974170A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11504648A (ja) | 1999-04-27 |
| WO1996035670A1 (en) | 1996-11-14 |
| CA2220538A1 (en) | 1996-11-14 |
| CN1144801A (zh) | 1997-03-12 |
| FI974170A0 (fi) | 1997-11-07 |
| EP0828712A1 (de) | 1998-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI974172A (fi) | B-adrenergisiä agonisteja | |
| DE69627551D1 (de) | Lüftströmungssteuervorrichtung | |
| DE69625472T2 (de) | Schraubrohrverbindung | |
| FI952109A0 (fi) | Siirtojohtoresonaattorisuodatin | |
| FI974170A0 (fi) | B-adrenergisiä agonisteja | |
| DE59610613D1 (de) | Leibungsbefestigungswinkel | |
| DK0863916T3 (da) | Polyfluoralkyl-tryptohantripeptid-thrombininhibitorer | |
| KR970009914U (ko) | 외등이 설치된 정자 | |
| DE69529336D1 (de) | Schrämlagemaschine | |
| KR970005654U (ko) | 환경캔 | |
| FI951528A0 (fi) | Tofttrappa; anordning foer stigning fraon vatten i baot | |
| FR2732104B1 (fr) | Repose-fleches | |
| NO955062D0 (no) | Rörledning | |
| FI2096U1 (fi) | Skyddssocka | |
| DE69636076D1 (de) | Filmrückspulvorrichtung | |
| FI1998U1 (fi) | Saekerhetsvaest | |
| FI2057U1 (fi) | Staedskrubb | |
| FI2095U1 (fi) | Aelgrepellent | |
| FI1861U1 (fi) | Kruka | |
| FI2152U1 (fi) | Staell foer mattvaett | |
| FI2277U1 (fi) | Marjanpoimintaharava | |
| FI2298U1 (fi) | Pintamuokkausjyrsin | |
| FI1919U1 (fi) | Inpassningsanordning | |
| FI954021A0 (fi) | Lutningsgivare | |
| FI956131A0 (fi) | Oevervakningssystem |